These patterns are consistent with established AD neuropathology: the decreased levels of proteins related to neurosynaptic growth and glial development (for example, NEFL, SYT1 and GFAP) in neurons and the brain likely reflect neuronal loss and synapse degeneration, accompanied by their subsequent shedding into the bloodstream. The gene discussed is GFAP; the disease is Alzheimer disease.